Abstract:The involvement of let-7 in the occurrence and progression of various cancers has been well-documented. However, the precise molecular mechanisms underlying its impact on oral cancer development remain unclear. In this study, we aimed to elucidate the role of let-7 in oral cancer progression and investigate its underlying molecular mechanisms. The expression of let-7 and high mobility group A2 (HMGA2) mRNA was assessed using the quantitative reverse transcription polymerase chain reaction. Western blot analysis was employed to detect the expression of key proteins in the PI3K/AKT signaling pathway as well as HMGA2 protein levels. The targeting relationship between let-7 and HMGA2 was predicted through bioinformatics methods and confirmed via luciferase reporter gene assay. The effects of let-7 and HMGA2 on the functionality of oral cancer cells were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, colony formation assay, Transwell assay, wound healing assay, and Annexin V/PI apoptosis assay. Additionally, the impact of let-7 on the growth of oral cancer cells in vivo was investigated by inducing subcutaneous tumor formation in nude mice. Let-7 effectively suppresses the proliferation, migration, and invasion of oral cancer cells by inhibiting the activation of the PI3K/AKT signaling pathway. HMGA2, a downstream target gene of let-7, exhibits high expression in oral cancer. However, overexpression of HMGA2 diminishes the inhibitory effects induced by let-7 overexpression on the proliferation, migration, and invasion of oral cancer cells. The occurrence and progression of oral cancer cells are inhibited by Let-7 through the downregulation of HMGA2, potentially mediated by the inhibition of PI3K/AKT signaling pathway activation.

Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.

Microrna Let-7g and Let-7i Inhibit Hepatoma Cell Growth Concurrently Via Downregulation of the Anti-Apoptotic Protein B-Cell Lymphoma-Extra Large

Let-7c Microrna Expression and Clinical Significance in Hepatocellular Carcinoma.

Advances in Research of Let-7 in Cancer

MicroRNA Let-7C Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma

MicroRNA Let-7C is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

Data from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Data from the &Lt;i>let-7&Lt;/i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

Pivotal Role Of Reduced Let-7g Expression In Breast Cancer Invasion And Metastasis

MicroRNA‑34a/c Function As Tumor Suppressors in Hep‑2 Laryngeal Carcinoma Cells and May Reduce GALNT7 Expression.

MicroRNA Let-7C-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments

Reexpression of Let-7g MicroRNA Inhibits the Proliferation and Migration Via K-Ras/HMGA2/Snail Axis in Hepatocellular Carcinoma

Let-7b-3p Inhibits Tumor Growth and Metastasis by Targeting the BRF2-mediated MAPK/ERK Pathway in Human Lung Adenocarcinoma

Let-7B/g Silencing Activates AKT Signaling to Promote Gastric Carcinogenesis

Microrna Let-7f Inhibits Tumor Invasion And Metastasis By Targeting Myh9 In Human Gastric Cancer

Let-7c Inhibits NSCLC Cell Proliferation by Targeting HOXA1.

The Let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells

MicroRNA Let-7B Inhibits Cell Proliferation Via Upregulation of P21 in Hepatocellular Carcinoma

Let-7a Functions As a Tumor Suppressor in Ewing's Sarcoma Cell Lines Partly by Targeting Cyclin-Dependent Kinase 6.

Let-7a Inhibits Proliferation and Induces Apoptosis by Targeting EZH2 in Nasopharyngeal Carcinoma Cells

Let-7 reduces the proliferation and migration of oral cancer cells via PI3K/AKT signaling pathway